Long-lasting antinociceptive effects of a novel dynorphin analogue, Tyr-D-Ala-Phe-Leu-Arg ψ (CH2NH) Arg-NH2, in mice

British Journal of Pharmacology

Volumn 132, Issue 8, 2001, Pages 1948-1956

  Hiramatsu, Masayuki ^a   Inoue, Kaori ^a   Ambo, Akihiro ^b   Sasaki, Yusuke ^b   Kameyama, Tsutomu ^a  

^a MEIJO UNIVERSITY   (Japan)

^b TOHOKU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Acetic acid induced writhing test; Hot plate test; Nor binaltorphimine; SK 9709; opioid receptor; opioid receptor

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE; DYNORPHIN A [1-8][1 (N METHYLTYROSINE) 7 (N METHYLARGININE) 8 DEXTRO LEUCINE N ETHYLAMIDE]; DYNORPHIN DERIVATIVE; MORPHINE; SK 9709; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CHEMICAL BOND; CONTROLLED STUDY; DRUG EFFECT; HOT PLATE TEST; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; WRITHING TEST;

EID: 0035036194     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0703982     Document Type: Article

References (48)

1. 2NH)
2. Permeability of the blood-brain barrier to peptides: An approach to the development of therapeutically useful analogs, peptide
3. Peptide transport systems for opiates across the blood-brain barrier
4. Ifenprodil blocks the excitatory effects of the opioid peptide dynorphin 1-17 on NMDA receptor-mediated currents in the CA3 region on the guinea pig hippocampus
5. A novel interaction between dynorphin (1-13) and an N-methyl-D-aspartate site
6. Specific receptor for the opioid peptide dynorphin: Structure-activity relationships
7. Dynorphin is a specific endogenous ligand of the κ opioid receptor
8. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction
9. Differential biotransformation of dynorphin A (1-17) and dynorphin A (1-13) peptides in human blood, ex vivo
10. 1-9 are ligands for the κ-subtype of opiate receptor
11. Dynorphin increases extracellular levels of excitatory amino acids in the brain through a non-opioid mechanism
12. Dynorphin-related peptides cause motor dysfunction in the rat through a non-opiate action
13. Studies on analgesic oligopeptides. VI. Further studies of synthesis and biological properties of tripeptide alkylamides, Tyr-D-Arg-Phe-X
14. 10]dynorphin (1-11) is a kappa-selective opioid analgesic in mice
15. Independent central and peripheral mediation of morphine-induced inhibition of gastrointestinal transit in rats
16. Dynorphin-(1-13), an extraordinarily potent opioid peptide
17. Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse
18. Antinociceptive profile of dynorphin in the rat
19. 1 dynorphin, A-(2-13) improves carbon monoxide-induced impairment of learning and memory in mice
20. Dynorphin A-(1-13) improves galanin-induced impairment of memory accompanied by blockage of reductions in acetylcholine release in rats
21. Effects of U-50,488H on scopolamine-, mecamylamine- and dizocilpine-induced learning and memory impairment in rats
22. Effects of dynorphin A-(1-13) on carbon monoxide-induced delayed amnesia in mice studied in a step-down type passive avoidance task
23. Dynorphin A modulates acute and chronic opioid effects
24. Intrathecal morphine in mice: A new technique
25. Preventing morphine antinociceptive tolerance by irreversible mu opioid antagonists before the onset of their antagonism
26. Dynorphin uses a non-opioid mechanism to potentiate N-methyl-D-aspartate currents in single rat periaqueductal gray neurons
27. Spinally administered dynorphin A produces long-lasting allodynia: Involvement of NMDA but not opioid receptors
28. A simplified method of evaluating dose effect experiments
29. A direct interaction of dynorphin-(1-13) with the N-methyl-D-aspartate (NMDA) receptor
30. A model of chronic pain in the rat: Response of multiple opioid systems to adjuvant-induced arthritis
31. Electrophysiological effects of dynorphin peptides on hippocampal pyramidal cells in rat
32. Analgesia produced by E-2078, a systemically active dynorphin analog, in mice
33. Spinal κ receptor-mediated analgesia of E-2078, a systemically active dynorphin analog, in mice
34. TIPP[ψ]: A highly potent and stable pseudopeptide delta opioid receptor antagonist with extraordinary delta selectivity
35. Non-opioid effects of dynorphins: Possible role of the NMDA receptor
36. Pharmacology of dynorphin
37. No tolerance to peripheral morphine analgesia in presence of opioid expression in inflamed synovia
38. Design and synthesis of metabolically stable analogues of dynorphin-A and their analgesic characteristics
39. Nor-binaltorphimine, a highly selective kappa-opioid antagonist in analgesic and receptor binding assays
40. Suppression by dynorphin A-(1-13) of the expression of opiate withdrawal and tolerance in mice
41. 1]dynorphin A peptides of the expression of opiate withdrawal and tolerance in morphine-dependent mice
42. Absorptive-mediated endocytosis of a dynorphin-like analgesic peptide, E-2078, into the blood-brain barrier
43. Single intrathecal injections of dynorphin A or des-tyrdynorphins produce long-lasting allodynia in rats: Blockade by MK-801 but not naloxone
44. Nonopiate effects of dynorphin and des-Tyr-dynorphin
45. Synthesis and structure-activity relationships of dynorphin A-(1-8) amide analogues
46. The degradation of dynorphin A in brain tissue in vivo and in vitro
47. Dynorphin A (1-8) analog, E-2078, is stable in human and rhesus monkeys
48. Dynorphin A (1-8) analog, E-2078, crosses the blood-brain barrier in rhesus monkeys